If MTAP deletions do indeed lead to MTA accumulation in primary human tumors, we would expect to observe dramatically higher MTA levels (on the order of >20-fold, as seen in in vitro intracellular data from Fig. 3c in that publication9) in a substantial fraction of GBM tumors. Here, MTAP is linked to glioblastoma.